Calder Biosciences Inc.: Funding, Investors & Team (Oct 2026)
Calder is a clinical-manufacturing stage biotechnology company producing next-generation vaccines that elicit best-in-class responses by using our 3D-Vaxlock™ technology to amplify the strength and breadth of protection. Viruses have evolved to become shapeshifters that can evade and distract our immune system by hiding some of their most vulnerable sites. History has shown that pandemics are not only lethal but also inevitable. Currently, the vaccines we know best poorly protect against pandemics and other viral outbreaks and leave many at-risk populations unprotected. By combining structure-based design as part of a novel manufacturing process, Calder’s unique 3D-Vaxlock™ technology generates molecular staples that lock vaccines into their most potent shape. Their initial focus is on generating a universal flu vaccine that protects against all seasonal strains and an RSV vaccine specifically for the elderly. With this platform, they have the ability to create treatments that better protect against life-threatening diseases with exceptional safety, efficacy, and durability. Calder’s next generation vaccines will prevent severe disease and deaths, alleviate a substantial burden on the healthcare system and allow billions of people to lead healthy lives.
Calder Biosciences Inc. has raised $1.4M across 2 funding rounds on record, the most recent a Seed of $530k announced in Sep 2023.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Calder Biosciences Inc. Company Profile and Key Stats
Latest funding round on record: Sep 2023.
Calder Biosciences Inc. Funding Rounds
Calder Biosciences Inc. raised $850k in an undisclosed round announced in Jul 2023.
2 months later, a Seed of $530k was announced in Sep 2023.
Calder Biosciences Inc. Founders and Leadership Team
Contact details for the Calder Biosciences Inc. team: 1 of 1 has an email address on file.
Start 14-day free trial →Calder Biosciences Inc. Funding Compared to Other Biotechnology Startups
Calder Biosciences Inc.'s latest round of $530k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Calder Biosciences Inc. in Biotechnology and New York
Companies Similar to Calder Biosciences Inc.
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Calder Biosciences Inc. Funding FAQs
What does Calder Biosciences Inc. do?
Calder is a clinical-manufacturing stage biotechnology company producing next-generation vaccines that elicit best-in-class responses by using our 3D-Vaxlock™ technology to amplify the strength and breadth of protection. Viruses have evolved to become shapeshifters that can evade and distract our immune system by hiding some of their most vulnerable sites. History has shown that pandemics are not only lethal but also inevitable. Currently, the vaccines we know best poorly protect against pandemics and other viral outbreaks and leave many at-risk populations unprotected. By combining structure-based design as part of a novel manufacturing process, Calder’s unique 3D-Vaxlock™ technology generates molecular staples that lock vaccines into their most potent shape. Their initial focus is on generating a universal flu vaccine that protects against all seasonal strains and an RSV vaccine specifically for the elderly. With this platform, they have the ability to create treatments that better protect against life-threatening diseases with exceptional safety, efficacy, and durability. Calder’s next generation vaccines will prevent severe disease and deaths, alleviate a substantial burden on the healthcare system and allow billions of people to lead healthy lives.
How much funding has Calder Biosciences Inc. raised?
Calder Biosciences Inc. has raised $1.4M across 2 rounds on record. The most recent is a Seed of $530k announced in Sep 2023.
When did Calder Biosciences Inc. last raise funding?
Calder Biosciences Inc.'s most recent funding round on record is a Seed of $530k, announced in Sep 2023.
Who is the CEO of Calder Biosciences Inc.?
Christopher Marshall is listed as CEO at Calder Biosciences Inc..
Where is Calder Biosciences Inc. headquartered?
Calder Biosciences Inc. is based in New York, United States.
How many employees does Calder Biosciences Inc. have?
Calder Biosciences Inc. is in the 1-10 employee band.
How does Calder Biosciences Inc.'s funding compare to other Biotechnology startups?
Calder Biosciences Inc.'s latest round of $530k is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Calder Biosciences Inc. Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Calder Biosciences Inc. is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.